Dialysis patients who respond poorly to erythropoietin (EPO) have a mortality risk more than 50% greater than those who do not require EPO. Medscape Medical News
AASK investigators are unsure why progression of kidney disease went unabated despite achieving blood-pressure targets of 0.22, were protected. Heartwire
Heavy, chronic use of marijuana causes increased levels of apolipoprotein C3, which in turn results in a major increase in triglyceride levels, a small study shows. The findings may explain some of the vascular effects of marijuana that have been observed, say the researchers. Heartwire
Researchers have found that two individual parts of the metabolic syndrome predict mortality in older adults better than the metabolic syndrome as a whole. Medscape Medical News
This Best Evidence Review weighs in on a study from The Annals of Internal Medicine on ARBs vs ACEIs for their role in chronic kidney disease. Medscape Family Medicine
For the first time, the American Society of Clinical Oncology has released several key research findings ahead of its annual meeting, being held later this month. Medscape Medical News
Study investigators were unsure why progression of kidney disease went unabated despite achieving blood-pressure targets of less than 130/80 mm Hg, but certain patients were protected. Medscape Medical News
Results from the trial -- halted last year due to safety concerns -- clearly point to increased deaths in high-risk coronary artery bypass graft patients randomized to aprotinin. Medscape Medical News
Children who survive cancer are at risk for premature cardiovascular disease and should be closely monitored for their whole lives. Medscape Medical News
A study shows that in patients aged 30 to 54 years, abdominal obesity and elevated glucose are components of the metabolic syndrome most strongly associated with short sleep duration. Medscape Medical News
